Form D · Biotechnology
InVasc Therapeutics, Inc.
Tucker, GA · CIK 0001496449
Offering snapshot reported Jul 13, 2010 · SEC filing
- Reported sold
- $3.15M Offering amount: $12M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 28, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 13, 2010 | Initial | $3,150,001 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $623K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-144812
Issuer shall pay a registered broker dealer up to 5% of the aggregate amount of cash received by Issuer from sales of remaining securities. MTS Securities, LLC shall receive a warrant for 63,415 preferred shares for acting as financial advisor.
Source: Form D, filed Jul 13, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Daniele Cardoso | Director |
| Larry Dillaha | Director |
| William D. Johnston | Director, Executive |
| William Schaeffer | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3562 Habersham At Northlake Building J, Suite A
Tucker, GA, 30084
Tucker, GA, 30084